Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
13.21
-0.80 (-5.71%)
At close: Nov 20, 2026, 4:00 PM EST
13.34
+0.13 (0.98%)
After-hours: Nov 20, 2026, 7:52 PM EST
Omeros Market Cap
Omeros has a market cap or net worth of $983.66 million as of November 20, 2026. It is the 9,606th most valuable company in the world and the 2,180th biggest in the United States. Its market cap has increased by 68.78% in one year.
Market Cap
983.66M
Enterprise Value
1.08B
1-Year Change
68.78%
Global Rank
Country Rank
#2,180 United States
Category
ChartMarket Cap Chart
Since October 8, 2009, Omeros's market cap has increased from $185.80M to $983.66M, an increase of 429.42%. That is a compound annual growth rate of 10.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 983.70M | -19.22% |
| Dec 31, 2025 | 1.22B | 112.70% |
| Dec 31, 2024 | 572.50M | 178.45% |
| Dec 29, 2023 | 205.60M | 44.99% |
| Dec 30, 2022 | 141.80M | -64.74% |
| Dec 31, 2021 | 402.10M | -54.34% |
| Dec 31, 2020 | 880.70M | 25.65% |
| Dec 31, 2019 | 700.90M | 28.37% |
| Dec 31, 2018 | 546.00M | -41.46% |
| Dec 29, 2017 | 932.70M | 119.10% |
| Dec 30, 2016 | 425.70M | -28.73% |
| Dec 31, 2015 | 597.30M | -29.26% |
| Dec 31, 2014 | 844.40M | 146.68% |
| Dec 31, 2013 | 342.30M | 154.69% |
| Dec 31, 2012 | 134.40M | 52.21% |
| Dec 30, 2011 | 88.30M | -50.20% |
| Dec 31, 2010 | 177.30M | 18.75% |
| Dec 31, 2009 | 149.30M | -19.64% |
| Oct 8, 2009 (IPO) | 185.80M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kardigan | 1.17B |
| Ascentage Pharma Group International | 1.15B |
| Vor Biopharma | 1.14B |
| Nektar Therapeutics | 1.11B |
| Inhibrx Biosciences | 1.10B |
| Alto Neuroscience | 1.06B |
| Alpha Tau Medical | 1.04B |
| Jade Biosciences | 1.04B |